|
|
|
Myeloid zinc finger 1 (MZF1) is the most important transcriptional factor for porcine follistatin promoter |
SUN Ya-meng, WANG Liang, YANG Xiu-qin, ZHANG Dong-jie, LIU Di |
1、College of Animal Sciences and Technology, Northeast Agricultural University, Harbin 150030, P.R.China
2、Heilongjiang Academy of Agricultural Sciences, Harbin 150086, P.R.China |
|
|
摘要 Follistatin (FS) is a secreted protein, which was originally isolated from porcine follicular fluid. Expression of follistatin is tightly regulated during porcine growth and development. To study the essential transcriptional regions of the porcine FS promoter, ten primer pairs were designed to amplify segments with different lengths of the FS promoter from –1 800 to +16 bp. The products were then inserted into the pGL3-basic vector to analyze the relative luciferase activity. The results showed that the most remarkable changes of promoter activity were observed between constructs (–302/+16 bp)-FS and (–180/+16 bp)-FS (P<0.01). Further research showed that the reconstructed reporter plasmid lacking myeloid zinc finger 1 (MZF1) binding sequence had significantly decreased luciferase activity (P<0.05). Furthermore, the FS protein expression was significantly increased in PK15 cells while the MZF1 was overexpressed, suggesting that the short sequence “TCCCCACC” (the recognition site of transcription factor MZF1) was the most important for FS transcription activation in the porcine.
Abstract Follistatin (FS) is a secreted protein, which was originally isolated from porcine follicular fluid. Expression of follistatin is tightly regulated during porcine growth and development. To study the essential transcriptional regions of the porcine FS promoter, ten primer pairs were designed to amplify segments with different lengths of the FS promoter from –1 800 to +16 bp. The products were then inserted into the pGL3-basic vector to analyze the relative luciferase activity. The results showed that the most remarkable changes of promoter activity were observed between constructs (–302/+16 bp)-FS and (–180/+16 bp)-FS (P<0.01). Further research showed that the reconstructed reporter plasmid lacking myeloid zinc finger 1 (MZF1) binding sequence had significantly decreased luciferase activity (P<0.05). Furthermore, the FS protein expression was significantly increased in PK15 cells while the MZF1 was overexpressed, suggesting that the short sequence “TCCCCACC” (the recognition site of transcription factor MZF1) was the most important for FS transcription activation in the porcine.
|
Received: 28 May 2014
Accepted:
|
Fund: This research was supported by the National Natural Science Foundation of China (31301955) and the China Agriculture Research System (CARS-36). |
Corresponding Authors:
LIU Di, Mobile: +86-13803644211, E-mail: liudi1963@163.com
E-mail: liudi1963@163.com
|
About author: SUN Ya-meng, E-mail: symbuster_1986@163.com; |
Cite this article:
SUN Ya-meng, WANG Liang, YANG Xiu-qin, ZHANG Dong-jie, LIU Di.
2015.
Myeloid zinc finger 1 (MZF1) is the most important transcriptional factor for porcine follistatin promoter. Journal of Integrative Agriculture, 14(7): 1383-1389.
|
Deng Y, Wang J, Wang G H, Jin Y, Luo X L, Xia X M, GongJ P, Hu J B. 2013. p55PIK transcriptionally activated byMZF1 promotes colorectal cancer cell proliferation. BioMedResearch International, doi: 10.1155/2013/868131Feijen A, Goumans M J, van den Eijnden-van Raaij A J.1994. Expression of activin subunits, activin receptors andfollistatin in postimplantation mouse embryos suggestsspecific developmental functions for different activins.Development, 120, 3621-3637de Groot E, Veltmaat J, Caricasole A, Defize L, van denEijnden-van Raaij A. 2000. Cloning and analysis of themouse follistatin promoter. Molecular Biology Reports, 27,129-139Horinaka M, Yoshida T, Tomosugi M, Yasuda S, Sowa Y, SakaiT. 2014. Myeloid zinc finger 1 mediates sulindac sulfideinducedupregulation of death receptor 5 of human coloncancer cells. Scientific Reports, 4, doi: 10.1038/srep06000Hromas R, Collins S J, Hickstein D, Raskind W, Deaven L L,O’Hara P, Hagen F S, Kaushansky K. 1991. A retinoic acidresponsivehuman zinc finger gene, MZF-1, preferentiallyexpressed in myeloid cells. The Journal of BiologicalChemistry, 266, 14183-14187Hsieh Y H, Wu T T, Huang C Y, Hsieh Y S, Liu J Y. 2007.Suppression of tumorigenicity of human hepatocellularcarcinomacells by antisense oligonucleotide MZF-1. TheChinese Journal of Physiology, 50, 9-15Jorgez C J, Klysik M, Jamin S P, Behringer R R, Matzuk MM. 2003. Granulosa cell-specific inactivation of follistatincauses female fertility defects. Molecular Endocrinology,18, 953-967Kimura F, Bonomi L M, Schneyer A L. 2011. Follistatin regulatesgerm cell nest breakdown and primordial follicle formation.Endocrinology, 152, 697-706Lee K B, Bettegowda A, Wee G, Ireland J J, Smith G W. 2009.Molecular determinants of oocyte competence: potentialfunctional role for maternal (oocyte-derived) follistatin inpromoting bovine early embryogenesis. Endocrinology,150, 2463-2471Ling N, Ying S Y, Ueno N, Esch F, Denoroy L, Guillemin R. 1985.Isolation and partial characterization of a Mr 32,000 proteinwith inhibin activity from porcine follicular fluid. Proceedingsof the National Academy of Sciences of the United Statesof America, 82, 7217-7221Luo X Y, Zhang X H, Shao W, Yin Y Q, Zhou J W. 2009.Crucial roles of MZF-1 in the transcriptional regulation ofapomorphine-induced modulation of FGF-2 expressionin astrocytic cultures. Journal of Neurochemistry, 108,952-961Maeshima A, Mishima K, Yamashita S, Nakasatomi M, MiyaM, Sakurai N, Sakairi T, Ikeuchi H, Hiromura K, HasegawaY, Kojima I, Nojima Y. 2014. Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a ratmodel of unilateral ureteral obstruction. BioMed ResearchInternational, doi: 10.1155/2014/376191Matzuk M M, Lu N, Vogel H, Sellheyer K, Roop D R, Bradley A.1995. Multiple defects and perinatal death in mice deficientin follistatin. Nature, 374, 360-363Morris J F, Hromas R, Rauscher F J. 1994. Characterization ofthe DNA-binding properties of the myeloid zinc finger proteinMZF1: two independent DNA-binding domains recognizetwo DNA consensus sequences with a common G-rich core.Molecular and Cellular Biology, 14, 1786-1795Mudduluru G, Vajkoczy P, Allgayer H. 2010. Myeloid zincfinger 1 induces migration, invasion, and in vivo metastasisthrough Axl gene expression in solid cancer. MolecularCancer Research, 8, 159-169Näf S, Escote X, Ballesteros M, Yañez R E, Simón-MuelaI, Gil P, Albaiges G, Vendrell J, Megia A. 2014. Serumactivin A and follistatin levels in gestational diabetes andthe association of the activin A-follistatin system withanthropometric parameters in offspring. PLOS ONE, 9,e92175.Noguchi F, Nakajima T, Inui S, Reddy J K, Itami S. 2014.Alteration of skin wound healing in keratinocyte-specificmediator complex subunit 1 null mice. PLOS ONE, 9,e102271.Sengupta D, Bhargava D K, Dixit A, Sahoo B S, Biswas S,Biswas G, Mishra S K. 2014. ERRβ signalling through FSTand BCAS2 inhibits cellular proliferation in breast cancercells. British Journal of Cancer, 110, 2144-2158Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M,Schneyer A. 2006. Biological activity of follistatin isoformsand follistatin-like-3 is dependent on differential cell surfacebinding and specificity for activin, myostatin and bonemorphogenetic proteins. Endocrinology, 147, 3586-3597Silva R N, Bueno P G, Avó L R S, Nonaka K O, Selistre-AraújoH S, Leal A M O. 2014. Effect of physical training on liverexpression of activin A and follistatin in a nonalcoholic fattyliver disease model in rats. Brazilian Journal of Medical andBiological Research, 47, 746-752Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S,Ling N, Titani K, Sugino H. 1993. Molecular heterogeneityof follistatin, an activin-binding protein. Higher affinity ofthe carboxyl-terminal truncated forms for heparan sulfateproteoglycans on the ovarian granulosa cell. The Journalof Biological Chemistry, 268, 15579-15587Tan N Y, Khachigian L M. 2009. Sp1 phosphorylation and itsregulation of gene transcription. Molecular and CellularBiology, 29, 2483-2488Winbanks C E, Weeks K L, Thomson R E, Sepulveda P V, BeyerC, Qian H, Chen J L, Allen J M, Lancaster G I, Febbraio M A,Harrison C A, McMullen J R, Chamberlain J S, GregorevicP. 2012. Follistatin-mediated skeletal muscle hypertrophy isregulated by Smad3 and mTOR independently of myostatin.Journal of Cell Biology, 197, 997-1008 |
No Suggested Reading articles found! |
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|